Drug Shortage Report for SEPTA DONEPEZIL
Report ID | 115452 |
Drug Identification Number | 02428482 |
Brand name | SEPTA DONEPEZIL |
Common or Proper name | DONEPEZIL HYDROCHLORIDE |
Company Name | SEPTA PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | DONEPEZIL HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30s and 100s |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-05-21 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-05-22 |
Company comments | supply issues |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7035 MAXWELL ROAD, UNIT # 2 MISSISSAUGA, ONTARIO CANADA L5S 1R5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-05-22 | English | Compare |
v2 | 2020-05-21 | French | Compare |
v1 | 2020-05-21 | English | Compare |
Showing 1 to 3 of 3